| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernias, Diaphragmatic, Congenital | 32 | 2024 | 399 | 7.260 |
Why?
|
| Extracorporeal Membrane Oxygenation | 19 | 2023 | 618 | 2.850 |
Why?
|
| Infant, Newborn | 77 | 2025 | 8259 | 2.150 |
Why?
|
| Hypertension, Pulmonary | 7 | 2024 | 439 | 1.460 |
Why?
|
| Ductus Arteriosus, Patent | 5 | 2024 | 143 | 1.270 |
Why?
|
| Oxygen | 6 | 2023 | 556 | 1.060 |
Why?
|
| Infant, Very Low Birth Weight | 5 | 2024 | 172 | 1.010 |
Why?
|
| Resuscitation | 6 | 2023 | 249 | 1.010 |
Why?
|
| Respiration | 2 | 2024 | 122 | 0.970 |
Why?
|
| Myofibromatosis | 1 | 2025 | 8 | 0.950 |
Why?
|
| Pneumothorax | 2 | 2024 | 76 | 0.840 |
Why?
|
| Thrombocytopenia | 3 | 2023 | 225 | 0.840 |
Why?
|
| Urine Specimen Collection | 1 | 2022 | 3 | 0.820 |
Why?
|
| Infant, Extremely Premature | 1 | 2023 | 87 | 0.790 |
Why?
|
| Hernia, Umbilical | 2 | 2020 | 42 | 0.760 |
Why?
|
| Lung | 10 | 2023 | 1487 | 0.760 |
Why?
|
| Specimen Handling | 1 | 2022 | 141 | 0.760 |
Why?
|
| Oximetry | 1 | 2023 | 171 | 0.760 |
Why?
|
| Humans | 96 | 2025 | 125331 | 0.750 |
Why?
|
| Nitric Oxide | 2 | 2024 | 485 | 0.750 |
Why?
|
| Patient Transfer | 2 | 2020 | 105 | 0.740 |
Why?
|
| Infant, Premature | 9 | 2025 | 830 | 0.740 |
Why?
|
| Infant | 29 | 2024 | 12581 | 0.700 |
Why?
|
| Catheterization | 5 | 2018 | 227 | 0.700 |
Why?
|
| Pulmonary Emphysema | 2 | 2020 | 93 | 0.690 |
Why?
|
| Platelet Transfusion | 3 | 2023 | 53 | 0.690 |
Why?
|
| Retrospective Studies | 38 | 2024 | 16344 | 0.680 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 3 | 2020 | 81 | 0.670 |
Why?
|
| Ribs | 1 | 2020 | 51 | 0.650 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 151 | 0.640 |
Why?
|
| Hand Deformities, Congenital | 1 | 2020 | 88 | 0.630 |
Why?
|
| Neck | 1 | 2020 | 135 | 0.620 |
Why?
|
| Intubation, Intratracheal | 6 | 2023 | 287 | 0.620 |
Why?
|
| Vasodilator Agents | 2 | 2018 | 202 | 0.590 |
Why?
|
| Infant, Premature, Diseases | 4 | 2024 | 244 | 0.560 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2016 | 90 | 0.560 |
Why?
|
| Hypotension | 2 | 2016 | 186 | 0.540 |
Why?
|
| Intensive Care Units, Neonatal | 6 | 2023 | 316 | 0.540 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 129 | 0.540 |
Why?
|
| Laryngoscopy | 4 | 2023 | 151 | 0.540 |
Why?
|
| Enterocolitis, Necrotizing | 5 | 2006 | 244 | 0.530 |
Why?
|
| Sildenafil Citrate | 1 | 2016 | 55 | 0.510 |
Why?
|
| Delphi Technique | 4 | 2024 | 210 | 0.510 |
Why?
|
| Respiration, Artificial | 3 | 2024 | 473 | 0.500 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2016 | 171 | 0.490 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 134 | 0.480 |
Why?
|
| Ultrasonography, Prenatal | 8 | 2023 | 972 | 0.450 |
Why?
|
| Respiratory Insufficiency | 2 | 2016 | 226 | 0.450 |
Why?
|
| Male | 36 | 2025 | 61573 | 0.440 |
Why?
|
| Pregnancy | 18 | 2023 | 7219 | 0.420 |
Why?
|
| Prenatal Diagnosis | 5 | 2023 | 600 | 0.410 |
Why?
|
| Echocardiography | 5 | 2023 | 1060 | 0.400 |
Why?
|
| Biopsy | 1 | 2016 | 1241 | 0.390 |
Why?
|
| Blood Transfusion | 4 | 2023 | 311 | 0.370 |
Why?
|
| Female | 39 | 2024 | 66836 | 0.370 |
Why?
|
| Fetal Diseases | 4 | 2017 | 456 | 0.370 |
Why?
|
| Length of Stay | 4 | 2024 | 1311 | 0.350 |
Why?
|
| Prognosis | 5 | 2024 | 4677 | 0.350 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2012 | 207 | 0.340 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2023 | 313 | 0.310 |
Why?
|
| Scrotum | 1 | 2009 | 25 | 0.310 |
Why?
|
| Cohort Studies | 9 | 2024 | 4837 | 0.290 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2008 | 53 | 0.290 |
Why?
|
| Trachea | 5 | 2023 | 203 | 0.280 |
Why?
|
| Platelet Count | 3 | 2023 | 137 | 0.280 |
Why?
|
| Antioxidants | 3 | 2005 | 353 | 0.280 |
Why?
|
| F2-Isoprostanes | 1 | 2007 | 20 | 0.280 |
Why?
|
| Liver Diseases | 3 | 2016 | 367 | 0.270 |
Why?
|
| Time-to-Treatment | 2 | 2018 | 186 | 0.270 |
Why?
|
| Testis | 1 | 2009 | 411 | 0.270 |
Why?
|
| Catheterization, Central Venous | 2 | 2021 | 128 | 0.260 |
Why?
|
| Administration, Inhalation | 2 | 2024 | 180 | 0.260 |
Why?
|
| Biomarkers | 3 | 2023 | 3093 | 0.250 |
Why?
|
| Chylothorax | 2 | 2024 | 27 | 0.240 |
Why?
|
| Triticum | 1 | 2005 | 34 | 0.240 |
Why?
|
| Transportation of Patients | 1 | 2015 | 54 | 0.240 |
Why?
|
| Anemia, Hemolytic | 1 | 2005 | 30 | 0.240 |
Why?
|
| Vinblastine | 1 | 2025 | 54 | 0.240 |
Why?
|
| Lenses | 1 | 2004 | 5 | 0.240 |
Why?
|
| Phytotherapy | 1 | 2005 | 49 | 0.240 |
Why?
|
| Pulmonary Surfactants | 1 | 2005 | 43 | 0.240 |
Why?
|
| Sirolimus | 2 | 2024 | 227 | 0.240 |
Why?
|
| Nasopharynx | 1 | 2005 | 79 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2020 | 102 | 0.230 |
Why?
|
| Dexamethasone | 1 | 2006 | 274 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2005 | 160 | 0.230 |
Why?
|
| Umbilical Arteries | 1 | 2004 | 98 | 0.230 |
Why?
|
| High-Frequency Ventilation | 1 | 2004 | 17 | 0.220 |
Why?
|
| Free Radicals | 1 | 2004 | 37 | 0.220 |
Why?
|
| Predictive Value of Tests | 6 | 2019 | 2175 | 0.220 |
Why?
|
| Ostomy | 1 | 2023 | 11 | 0.220 |
Why?
|
| Preoperative Period | 1 | 2024 | 88 | 0.220 |
Why?
|
| Gentamicins | 1 | 2004 | 94 | 0.220 |
Why?
|
| Blood Gas Analysis | 1 | 2023 | 86 | 0.210 |
Why?
|
| Lymphangioma | 1 | 2003 | 24 | 0.210 |
Why?
|
| Dissent and Disputes | 1 | 2003 | 32 | 0.210 |
Why?
|
| Glucocorticoids | 1 | 2006 | 384 | 0.210 |
Why?
|
| Time Factors | 6 | 2024 | 6318 | 0.210 |
Why?
|
| Capnography | 1 | 2023 | 13 | 0.210 |
Why?
|
| Patient Discharge | 2 | 2024 | 496 | 0.210 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2002 | 5 | 0.210 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2002 | 9 | 0.210 |
Why?
|
| Medical Staff, Hospital | 1 | 2003 | 93 | 0.210 |
Why?
|
| Critical Care | 2 | 2015 | 657 | 0.210 |
Why?
|
| Treatment Refusal | 1 | 2003 | 78 | 0.200 |
Why?
|
| Professional-Family Relations | 1 | 2003 | 93 | 0.200 |
Why?
|
| Treatment Outcome | 14 | 2023 | 12290 | 0.200 |
Why?
|
| Catheterization, Peripheral | 1 | 2004 | 125 | 0.200 |
Why?
|
| Laryngeal Neoplasms | 1 | 2003 | 84 | 0.200 |
Why?
|
| Methotrexate | 1 | 2025 | 335 | 0.200 |
Why?
|
| Vascular Malformations | 1 | 2024 | 89 | 0.200 |
Why?
|
| Pediatrics | 2 | 2017 | 1158 | 0.200 |
Why?
|
| Fetoscopy | 4 | 2023 | 447 | 0.200 |
Why?
|
| Health Information Systems | 1 | 2023 | 31 | 0.200 |
Why?
|
| Risk Factors | 4 | 2024 | 10287 | 0.200 |
Why?
|
| Quality of Health Care | 1 | 2015 | 391 | 0.200 |
Why?
|
| Drug Resistance | 1 | 2002 | 255 | 0.190 |
Why?
|
| Chromosome Deletion | 1 | 2005 | 652 | 0.190 |
Why?
|
| Lymphatic Abnormalities | 1 | 2021 | 34 | 0.180 |
Why?
|
| Logistic Models | 2 | 2024 | 1808 | 0.180 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 2 | 2020 | 9 | 0.180 |
Why?
|
| Infant, Low Birth Weight | 4 | 2005 | 167 | 0.180 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 2906 | 0.180 |
Why?
|
| Airway Obstruction | 1 | 2023 | 165 | 0.180 |
Why?
|
| Pleural Effusion | 1 | 2021 | 102 | 0.180 |
Why?
|
| Central Venous Catheters | 1 | 2021 | 39 | 0.180 |
Why?
|
| Blood Platelets | 1 | 2023 | 325 | 0.170 |
Why?
|
| Consensus | 1 | 2024 | 644 | 0.170 |
Why?
|
| Obstetrics | 1 | 2023 | 238 | 0.170 |
Why?
|
| Insulin | 1 | 2005 | 1203 | 0.170 |
Why?
|
| Positive-Pressure Respiration | 1 | 2020 | 84 | 0.170 |
Why?
|
| Critical Illness | 3 | 2021 | 601 | 0.170 |
Why?
|
| Respiratory System Abnormalities | 1 | 2020 | 42 | 0.170 |
Why?
|
| Chromosome Aberrations | 3 | 2020 | 620 | 0.170 |
Why?
|
| Pneumopericardium | 1 | 2019 | 3 | 0.160 |
Why?
|
| Emphysema | 1 | 2020 | 67 | 0.160 |
Why?
|
| Heart Defects, Congenital | 3 | 2019 | 1830 | 0.160 |
Why?
|
| Fatal Outcome | 1 | 2020 | 357 | 0.160 |
Why?
|
| Glutathione | 1 | 2000 | 195 | 0.160 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2020 | 149 | 0.150 |
Why?
|
| Learning | 1 | 2002 | 360 | 0.150 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2018 | 20 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 3 | 2015 | 1270 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2019 | 3603 | 0.150 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 33 | 0.150 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2002 | 318 | 0.150 |
Why?
|
| Reflex | 1 | 2018 | 51 | 0.150 |
Why?
|
| Alprostadil | 1 | 2018 | 27 | 0.150 |
Why?
|
| Herniorrhaphy | 1 | 2018 | 81 | 0.140 |
Why?
|
| Fetal Therapies | 1 | 2018 | 80 | 0.140 |
Why?
|
| Head | 2 | 2015 | 103 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 156 | 0.140 |
Why?
|
| Elective Surgical Procedures | 1 | 2018 | 158 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 875 | 0.140 |
Why?
|
| Survival Rate | 5 | 2018 | 2046 | 0.140 |
Why?
|
| Transposition of Great Vessels | 1 | 2018 | 132 | 0.140 |
Why?
|
| Pneumonectomy | 1 | 2018 | 143 | 0.140 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2018 | 479 | 0.140 |
Why?
|
| Quality of Life | 2 | 2018 | 1946 | 0.130 |
Why?
|
| Drug Administration Routes | 1 | 2016 | 33 | 0.130 |
Why?
|
| Balloon Occlusion | 1 | 2017 | 46 | 0.130 |
Why?
|
| Parents | 1 | 2003 | 1023 | 0.130 |
Why?
|
| Infusions, Intravenous | 2 | 2016 | 554 | 0.130 |
Why?
|
| Peptide Fragments | 2 | 2023 | 781 | 0.130 |
Why?
|
| Thrombosis | 1 | 2021 | 519 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2018 | 780 | 0.130 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 142 | 0.120 |
Why?
|
| Registries | 2 | 2012 | 1431 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 338 | 0.120 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2016 | 81 | 0.120 |
Why?
|
| Mitochondria | 1 | 2000 | 679 | 0.120 |
Why?
|
| Survivors | 1 | 2018 | 338 | 0.120 |
Why?
|
| Lung Volume Measurements | 3 | 2023 | 75 | 0.120 |
Why?
|
| Prenatal Care | 3 | 2023 | 348 | 0.120 |
Why?
|
| Hypothermia, Induced | 1 | 2016 | 170 | 0.120 |
Why?
|
| Hemodynamics | 2 | 2016 | 851 | 0.120 |
Why?
|
| Simulation Training | 1 | 2017 | 140 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 728 | 0.110 |
Why?
|
| Anemia, Neonatal | 1 | 1994 | 8 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2016 | 681 | 0.110 |
Why?
|
| Hypertension | 1 | 2023 | 1330 | 0.110 |
Why?
|
| Hernia, Diaphragmatic | 3 | 2012 | 98 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 960 | 0.110 |
Why?
|
| Erythropoietin | 1 | 1994 | 104 | 0.110 |
Why?
|
| Birth Weight | 2 | 2023 | 345 | 0.110 |
Why?
|
| Vasopressins | 1 | 2013 | 44 | 0.100 |
Why?
|
| Gene Dosage | 2 | 2012 | 444 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2017 | 3309 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2089 | 0.100 |
Why?
|
| Gestational Age | 4 | 2019 | 1168 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 2429 | 0.100 |
Why?
|
| LIM Domain Proteins | 1 | 2012 | 62 | 0.100 |
Why?
|
| Genome, Human | 2 | 2011 | 1293 | 0.100 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 134 | 0.100 |
Why?
|
| Enteral Nutrition | 2 | 2024 | 258 | 0.100 |
Why?
|
| Esophageal Atresia | 1 | 2012 | 51 | 0.100 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2012 | 48 | 0.090 |
Why?
|
| Texas | 5 | 2019 | 3582 | 0.090 |
Why?
|
| Limb Deformities, Congenital | 1 | 2012 | 105 | 0.090 |
Why?
|
| Catheters | 1 | 2012 | 86 | 0.090 |
Why?
|
| Tertiary Care Centers | 2 | 2018 | 237 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2006 | 3439 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 274 | 0.090 |
Why?
|
| Phenotype | 1 | 2020 | 4268 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 503 | 0.080 |
Why?
|
| Research Design | 3 | 2023 | 693 | 0.080 |
Why?
|
| Child | 8 | 2023 | 24575 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 1898 | 0.080 |
Why?
|
| Humidity | 1 | 2008 | 25 | 0.070 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 129 | 0.070 |
Why?
|
| Hot Temperature | 1 | 2008 | 136 | 0.070 |
Why?
|
| Chemoprevention | 1 | 2008 | 58 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3741 | 0.070 |
Why?
|
| Dinoprost | 1 | 2007 | 28 | 0.070 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2007 | 79 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2017 | 1182 | 0.070 |
Why?
|
| Catheters, Indwelling | 2 | 2021 | 148 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2002 | 818 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 394 | 0.060 |
Why?
|
| Platelet Activating Factor | 1 | 2006 | 28 | 0.060 |
Why?
|
| Insulin, Long-Acting | 1 | 2005 | 4 | 0.060 |
Why?
|
| Insulin Glargine | 1 | 2005 | 7 | 0.060 |
Why?
|
| Congenital Abnormalities | 1 | 2009 | 257 | 0.060 |
Why?
|
| Ohio | 1 | 2015 | 87 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2008 | 258 | 0.060 |
Why?
|
| Umbilical Veins | 1 | 2005 | 71 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 367 | 0.060 |
Why?
|
| Pneumonia | 2 | 2012 | 325 | 0.060 |
Why?
|
| Tachycardia | 1 | 2005 | 70 | 0.060 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2004 | 10 | 0.060 |
Why?
|
| Airway Management | 1 | 2015 | 62 | 0.060 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2008 | 345 | 0.060 |
Why?
|
| Benchmarking | 1 | 2015 | 137 | 0.060 |
Why?
|
| Gastrointestinal Contents | 1 | 2004 | 13 | 0.060 |
Why?
|
| Short Bowel Syndrome | 1 | 2005 | 65 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 2901 | 0.060 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2004 | 13 | 0.060 |
Why?
|
| Indomethacin | 1 | 2004 | 84 | 0.060 |
Why?
|
| Child, Preschool | 5 | 2018 | 14123 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2004 | 257 | 0.050 |
Why?
|
| Homeopathy | 1 | 2003 | 3 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2003 | 20 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2005 | 172 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 1033 | 0.050 |
Why?
|
| Trisomy | 1 | 2004 | 102 | 0.050 |
Why?
|
| Retinopathy of Prematurity | 1 | 2004 | 57 | 0.050 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 218 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2652 | 0.050 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 70 | 0.050 |
Why?
|
| Cardiovascular Agents | 1 | 2004 | 89 | 0.050 |
Why?
|
| Cholestasis | 1 | 2005 | 154 | 0.050 |
Why?
|
| ROC Curve | 2 | 2015 | 571 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2008 | 765 | 0.050 |
Why?
|
| CHO Cells | 1 | 2002 | 169 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2004 | 143 | 0.050 |
Why?
|
| Larynx | 1 | 2003 | 72 | 0.050 |
Why?
|
| Parenteral Nutrition | 1 | 2024 | 196 | 0.050 |
Why?
|
| Adult | 5 | 2017 | 29607 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2002 | 312 | 0.050 |
Why?
|
| Cricetinae | 1 | 2002 | 422 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 1026 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2002 | 165 | 0.050 |
Why?
|
| Mosaicism | 1 | 2004 | 239 | 0.050 |
Why?
|
| Octreotide | 1 | 2021 | 23 | 0.050 |
Why?
|
| Stomach | 1 | 2004 | 270 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2002 | 461 | 0.050 |
Why?
|
| Propensity Score | 1 | 2023 | 221 | 0.050 |
Why?
|
| Neonatology | 1 | 2002 | 53 | 0.050 |
Why?
|
| Thorax | 1 | 2021 | 73 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2015 | 545 | 0.050 |
Why?
|
| Patient Safety | 1 | 2015 | 398 | 0.040 |
Why?
|
| Liver | 2 | 2019 | 1748 | 0.040 |
Why?
|
| Diaphragm | 1 | 2021 | 98 | 0.040 |
Why?
|
| Transfection | 1 | 2002 | 1076 | 0.040 |
Why?
|
| Gastroesophageal Reflux | 1 | 2024 | 327 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 2057 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 415 | 0.040 |
Why?
|
| Intestines | 1 | 2023 | 577 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2019 | 51 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6160 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2022 | 1253 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 120 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2019 | 166 | 0.040 |
Why?
|
| Hospitalization | 2 | 2023 | 1790 | 0.040 |
Why?
|
| Hyperoxia | 1 | 2000 | 129 | 0.040 |
Why?
|
| Decision Making | 1 | 2003 | 657 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 441 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 397 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 1391 | 0.040 |
Why?
|
| Endoscopy | 1 | 2019 | 280 | 0.040 |
Why?
|
| Fetus | 1 | 2021 | 586 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2000 | 495 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2019 | 216 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 77 | 0.030 |
Why?
|
| Epithelium | 1 | 2018 | 365 | 0.030 |
Why?
|
| Laryngoscopes | 1 | 2018 | 69 | 0.030 |
Why?
|
| Animals | 3 | 2018 | 34298 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2810 | 0.030 |
Why?
|
| Rats | 1 | 2002 | 3725 | 0.030 |
Why?
|
| Manikins | 1 | 2017 | 136 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 315 | 0.030 |
Why?
|
| Video Recording | 1 | 2017 | 183 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 5166 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 17 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2018 | 264 | 0.030 |
Why?
|
| Patient Selection | 1 | 2019 | 696 | 0.030 |
Why?
|
| Religion and Medicine | 1 | 1994 | 25 | 0.030 |
Why?
|
| Adolescent | 3 | 2018 | 19419 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3431 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 760 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 225 | 0.030 |
Why?
|
| Teratoma | 1 | 2015 | 126 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1117 | 0.030 |
Why?
|
| Lypressin | 1 | 2013 | 16 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 765 | 0.030 |
Why?
|
| Tracheostomy | 1 | 2015 | 197 | 0.020 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 127 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1065 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2012 | 29 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2015 | 595 | 0.020 |
Why?
|
| Age Factors | 1 | 2018 | 2824 | 0.020 |
Why?
|
| Anal Canal | 1 | 2012 | 82 | 0.020 |
Why?
|
| Vena Cava, Superior | 1 | 2012 | 57 | 0.020 |
Why?
|
| Diaphragmatic Eventration | 1 | 2011 | 7 | 0.020 |
Why?
|
| Spine | 1 | 2012 | 142 | 0.020 |
Why?
|
| Mutation | 2 | 2018 | 5900 | 0.020 |
Why?
|
| Asphyxia Neonatorum | 1 | 1991 | 15 | 0.020 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 99 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2011 | 79 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 87 | 0.020 |
Why?
|
| Intensive Care, Neonatal | 1 | 1991 | 54 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 1400 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 279 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2011 | 140 | 0.020 |
Why?
|
| Esophagus | 1 | 2012 | 223 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2011 | 150 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3751 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 3134 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2017 | 1001 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 589 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 398 | 0.020 |
Why?
|
| Heart Atria | 1 | 2012 | 316 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 573 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2011 | 372 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 809 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 780 | 0.020 |
Why?
|
| Palivizumab | 1 | 2008 | 47 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 989 | 0.020 |
Why?
|
| Alleles | 1 | 2012 | 1617 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2007 | 139 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3055 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2007 | 119 | 0.020 |
Why?
|
| Pleurisy | 1 | 2006 | 6 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2007 | 143 | 0.020 |
Why?
|
| Laryngeal Diseases | 1 | 2006 | 32 | 0.020 |
Why?
|
| Fetal Macrosomia | 1 | 2005 | 20 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 1363 | 0.010 |
Why?
|
| Electric Countershock | 1 | 2005 | 67 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2008 | 510 | 0.010 |
Why?
|
| Laparotomy | 1 | 2005 | 135 | 0.010 |
Why?
|
| Bias | 1 | 2004 | 133 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 9066 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 2059 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 17736 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 2602 | 0.010 |
Why?
|
| Glucose | 1 | 2005 | 878 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1691 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2007 | 1013 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 1756 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2005 | 976 | 0.010 |
Why?
|
| Stroke | 1 | 2006 | 979 | 0.010 |
Why?
|
| Heart Failure | 1 | 2006 | 2298 | 0.010 |
Why?
|
| Apgar Score | 1 | 1991 | 48 | 0.010 |
Why?
|
| India | 1 | 1991 | 211 | 0.010 |
Why?
|
| United States | 1 | 2004 | 10922 | 0.000 |
Why?
|